Valuation: Sanofi

Market Cap 96.07B 111B 89.22B 82.28B 155B 10,560B 158B 1,056B 414B 5,245B 415B 406B 17,637B P/E 2026 *
16.3x
P/E 2027 * 11.1x
Enterprise Value 106B 122B 98.32B 90.67B 171B 11,637B 174B 1,164B 456B 5,780B 458B 448B 19,436B EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.02x
Free-Float
89.21%
Yield 2026 *
4.98%
Yield 2027 * 5.64%
1 day-4.37%
1 week-1.08%
Current month+0.54%
1 month+0.54%
3 months-7.92%
6 months-8.82%
Current year-11.49%
1 week 41.42
Extreme 41.42
45.66
1 month 41.27
Extreme 41.27
45.66
Current year 40.89
Extreme 40.89
49.42
1 year 40.89
Extreme 40.89
52.68
3 years 40.89
Extreme 40.89
60.12
5 years 36.91
Extreme 36.91
60.12
10 years 36.81
Extreme 36.8101
60.12
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer 51 2023-09-10
Director TitleAgeSince
Director/Board Member 60 2019-04-29
Director/Board Member 57 2020-04-27
Director/Board Member 64 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-4.37%-1.08% - - 109B
-4.55%-2.61%+51.95%+154.09% 1,079B
-3.66%-1.33%+52.95%+52.70% 640B
-2.24%+0.19%+35.97%+72.09% 465B
-2.29%+6.32%+36.18%+31.18% 353B
-2.28%+1.15%+33.85%+40.48% 301B
-3.15%+0.14%+14.00%+15.03% 271B
-2.12%+3.57%-4.61%-37.38% 228B
0.00%+4.34%+28.63%+65.55% 209B
-1.09%+0.32%+14.40%+72.42% 165B
Average -2.68%+4.83%+29.26%+51.80% 412.19B
Weighted average by Cap. -3.11%+4.86%+37.93%+74.91%

Financials

2026 *2027 *
Net sales 47.09B 54.22B 43.73B 40.33B 75.97B 5,176B 77.35B 518B 203B 2,571B 204B 199B 8,645B 50.48B 58.12B 46.88B 43.23B 81.43B 5,548B 82.91B 555B 217B 2,756B 218B 213B 9,267B
Net income 6.5B 7.49B 6.04B 5.57B 10.49B 715B 10.68B 71.5B 28B 355B 28.12B 27.5B 1,194B 9.44B 10.86B 8.76B 8.08B 15.22B 1,037B 15.5B 104B 40.62B 515B 40.8B 39.91B 1,732B
Net Debt 9.8B 11.29B 9.1B 8.4B 15.81B 1,077B 16.1B 108B 42.2B 535B 42.38B 41.45B 1,800B 6.15B 7.07B 5.71B 5.26B 9.91B 675B 10.09B 67.56B 26.45B 335B 26.57B 25.99B 1,128B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-07-30 US$42.89 -4.37% 10,175,801
26-07-29 US$44.85 -1.52% 3,512,249
26-07-28 US$45.54 +3.50% 2,850,035
26-07-27 US$44.00 +1.50% 2,955,041
26-07-24 US$43.35 -0.02% 3,067,638
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
79.92EUR
Average target price
96.14EUR
Spread / Average Target
+20.29%

Quarterly revenue - Rate of surprise